You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • S99 Efficacy of nintedanib on acute exacerbations reported as serious adverse events in the inpulsis® trials in idiopathic pulmonary fibrosis (IPF)

Article metrics

Article menu

Download PDFPDF

Idiopathic Pulmonary Fibrosis Therapy
S99 Efficacy of nintedanib on acute exacerbations reported as serious adverse events in the inpulsis® trials in idiopathic pulmonary fibrosis (IPF)
Free

 

Online download statistics by month:

Online download statistics by month: November 2016 to March 2024

AbstractFullPdf
Nov 20163406
Dec 20162506
Jan 20174101
Feb 20171903
Mar 20171202
Apr 20172104
May 20171604
Jun 20171902
Jul 20171601
Aug 20174401
Sep 20172400
Oct 20172601
Nov 20171400
Dec 20174400
Jan 20182200
Feb 20183900
Mar 20184602
Apr 20184000
May 20182000
Jun 20182200
Jul 20182602
Aug 20182400
Sep 20183000
Oct 20185201
Nov 20181800
Dec 20182002
Jan 20191800
Feb 2019600
Mar 2019500
Apr 2019800
May 20191201
Jun 20191000
Jul 2019800
Aug 2019800
Sep 2019400
Oct 20191600
Nov 20191603
Dec 2019405
Jan 2020802
Feb 2020202
Mar 2020604
Apr 2020202
May 2020602
Jun 2020203
Jul 20201702
Aug 2020001
Sep 20202002
Oct 20201001
Nov 20201105
Dec 2020200
Jan 2021602
Feb 2021304
Mar 20211003
Apr 2021401
May 2021203
Jun 2021002
Jul 2021004
Aug 2021002
Sep 2021005
Oct 20218016
Nov 202114014
Dec 20211603
Jan 20221602
Feb 2022400
Mar 20222202
Apr 2022403
May 20221008
Jun 2022203
Jul 20221100
Aug 20221201
Sep 2022408
Oct 2022902
Nov 2022801
Dec 20221002
Jan 2023402
Feb 2023400
Mar 20231301
Apr 2023800
May 2023204
Jul 2023402
Aug 2023500
Sep 2023601
Oct 2023601
Nov 2023904
Dec 2023600
Jan 2024201
Feb 20241001
Mar 2024403
Total11730184